Postcardioplegia ventricular fibrillation: no impact on subsequent survival

Sven Martin Almdahl1, Terje Veel, Magne Eide

  • 1Department of Cardiac Surgery, Feiring Heart Clinic , Feiring , Norway.

Insights

Post-cardiac arrest, initial rhythm (ventricular fibrillation or non-VF) and potassium treatment for VF did not impact long-term survival. Electrical conversion after failed potassium treatment showed a trend toward increased mortality.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Clinical Outcomes Research

Background:

  • Initial rhythm after aortic declamping in cardiac surgery can be ventricular fibrillation (VF) or non-VF.
  • Ventricular fibrillation (VF) is typically managed with potassium-induced conversion, with direct-current countershock reserved for treatment failures.

Purpose of the Study:

  • To investigate differences in patient outcomes based on initial rhythm and VF treatment post-cardioplegic arrest.
  • To determine the association between postcardioplegia VF, potassium treatment, and long-term all-cause mortality.

Main Methods:

  • Retrospective analysis of 12,113 cardiac surgery patients (1999-2010).
  • Survival data obtained from the Norwegian National Registry.
  • Cox multivariable modeling adjusted for baseline clinical, biochemical, and medication data.

Main Results:

  • No significant difference in adjusted survival between patients with no postcardioplegia VF and those with successful potassium-induced conversion.
  • Patients requiring electrical conversion after failed potassium treatment demonstrated a non-significant trend towards increased mortality (HR 1.19, 95% CI 0.99-1.4).
  • Overall all-cause mortality was 24.9% over a mean follow-up of 7.4 years.

Conclusions:

  • This study is the first to report on postcardioplegia VF, potassium treatment, and patient outcomes.
  • No impact of postcardioplegia VF or its potassium-based treatment on all-cause mortality was observed.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
1.2K
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
460
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
804